Form 4 for NEO NEOGENOMICS INC
Accepted 2025-02-25 00:00:00 ET · period of report 2025-02-21 · accession 0001077183-25-000042 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-25 | 2025-02-23 | NEO | Harris Melody | Pres, Chf Ops Off, Informatics | M - OptEx | $0.00 | +8,443 | 111.8K | +8% | $0 |
| D | 2025-02-25 | 2025-02-23 | NEO | Harris Melody | Pres, Chf Ops Off, Informatics | F - Tax | $0.00 | -2,056 | 109.8K | -2% | $0 |
| D | 2025-02-25 | 2025-02-23 | NEO | Harris Melody | Pres, Chf Ops Off, Informatics | M - OptEx | $0.00 | -8,443 | 16.9K | -33% | $0 |
| DM | 2025-02-25 | 2025-02-21 | NEO | Harris Melody | Pres, Chf Ops Off, Informatics | A - Grant | $0.00 | +227.6K | 84.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-23 | M | A | 8,443 | $0.00 | 111,811 | D | — | — | (F1) Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting. (F2) This balance includes 548 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan. The shares were acquired in transactions exempt from Section 16b-3. |
| 2 | Common | Common Stock | 2025-02-23 | F | D | 2,056 | $0.00 | 109,755 | D | — | — | (F3) Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units. |
| 3 | Derivative | Restricted Stock Unit | 2025-02-23 | M | D | 8,443 | $0.00 | 16,886 | D | $0.00 · — to — | 8,443 Common Stock | (F8) On February 23, 2024, Ms. Harris was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date. (F7) Once vested, the shares of common stock are not subject to expiration. |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-02-21 | A | A | 143,266 | $0.00 | 143,266 | D | $13.05 · — to 2035-02-21 | 143,266 Common Stock | (F4) This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%. (F5) On February 21, 2025, Ms. Harris was granted 143,266 stock options. These options vest ratably over the first three anniversary dates of the grant date. |
| 5 | Derivative | Restricted Stock Unit | 2025-02-21 | A | A | 84,317 | $0.00 | 84,317 | D | $0.00 · — to — | 84,317 Common Stock | (F6) On February 21, 2025, Ms. Harris was granted 84,317 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date. (F7) Once vested, the shares of common stock are not subject to expiration. |